| Literature DB >> 26290078 |
Xinqiong Li1, Ling Zhu2,3, Xiao Liu4, Xiangang Sun5, Yuanchen Zhou6, Qiaoli Lang7, Ping Li8, Yuhan Cai9, Xiaogai Qiao10, Zhiwen Xu11,12.
Abstract
BACKGROUND: Porcine parvovirus (PPV), a member of the Parvoviridae family, causes great economic loss in the swine industry worldwide. MicroRNAs (miRNAs) are a class of non-protein-coding genes that play many diverse and complex roles in viral infections. FINDING: Aiming to determine the impact of PPV infections on the cellular miRNAome, we used high-throughput sequencing to sequence two miRNA libraries prepared from porcine kidney 15 (PK-15) cells under normal conditions and during PPV infection. There was differential miRNA expression between the uninfected and infected cells: 65 miRNAs were upregulated and 128 miRNAs were downregulated. We detected the expression of miR-10b, miR-20a, miR-19b, miR-181a, miR-146b, miR-18a, and other previously identified immune-related miRNAs. Gene Ontology analysis and KEGG function annotations of the host target genes suggested that the miRNAs are involved in complex cellular pathways, including cellular metabolic processes, immune system processes, and gene expression.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26290078 PMCID: PMC4545981 DOI: 10.1186/s12985-015-0359-4
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
RT-qPCR primers
| Gene | RT primer | |
|---|---|---|
| U6 | 5’CGCTTCACGAATTTGCGTGTCAT3’ | |
| miR-RT Primer | 5’GTCGGTGTCGTGGAGTCGTTTGCAATTGCACTGGATTTTTTTTTTTTTTTTTTV3’ | |
| V = A, G, C | ||
| Gene | Forward primer (5’–3’) | Reversed primer (5’–3’) |
| ssc-miR-10b | TACCCTGTAGAACCGAATTTGT | GTCGGTGTCGTGGAGTCG |
| ssc-miR-30a-5p | TGTAAACATCCTCGACTGGAAG | GTCGGTGTCGTGGAGTCG |
| ssc-miR-16 | TAGCAGCACGTAAATATTGGC | GTCGGTGTCGTGGAGTCG |
| ssc-miR-17-5p | CAAAGTGCTTACAGTGCAGGTAG | GTCGGTGTCGTGGAGTCG |
| ssc-miR-192 | CTGACCTATGAATTGACA | GTCGGTGTCGTGGAGTCG |
| ssc-miR-21 | TAGCTTATCAGACTGATGTTGA | GTCGGTGTCGTGGAGTCG |
| ssc-miR-19b | TGTGCAAATCCATGCAAAAC | GTCGGTGTCGTGGAGTCG |
| ssc-miR-18a | TAAGGTGCATCTAGTGCAGATA | GTCGGTGTCGTGGAGTCG |
| ssc-miR-152 | TCAGTGCATGACAGAACTTGG | GTCGGTGTCGTGGAGTCG |
| ssc-miR-novel-chr13_10861 | TTCAAGTAACCCAGGATAGGCT | GTCGGTGTCGTGGAGTCG |
| U6 | TCGCTTTGGCAGCACCTAT | AATATGGAACGCTTCGCAAA |
Fig. 1Length distribution of miRNA reads from Solexa sequencing. a Adapter-trimmed reads in the infected library; b adapter-trimmed reads in the control library
Top 50 miRNAs significantly up- or downregulated in PK-15 cells in order of fold change (FC)
| Annotation | Normalized read counts | length | type | FC | Number of target genes | |
|---|---|---|---|---|---|---|
| infected | control | |||||
| ssc-miR-10b | 42,588 | 1162 | 22 | Up | 36.35 | 738 |
| ssc-miR-192 | 3769 | 102 | 21 | Up | 33.74 | 718 |
| ssc-miR-20a | 2432 | 116 | 22 | Up | 19.38 | 1490 |
| ssc-miR-296-3p | 195 | 3 | 21 | Up | 15.77 | 1863 |
| ssc-miR-novel-chr17-18987 | 195 | 3 | 19 | Up | 15.77 | 1864 |
| ssc-miR-92b-3p | 2215 | 133 | 22 | Up | 15.56 | 1757 |
| ssc-miR-30a-5p | 98,034 | 6320 | 22 | Up | 15.49 | 1147 |
| ssc-miR-novel-chr12-7961 | 1886 | 191 | 22 | Up | 9.43 | 1357 |
| ssc-miR-novel-chr14-13888 | 582 | 58 | 23 | Up | 8.71 | 1368 |
| ssc-miR-34a | 358 | 37 | 22 | Up | 7.83 | 1663 |
| ssc-miR-novel-chr16-17559 | 55 | 0 | 22 | Up | 6.5 | 1610 |
| ssc-miR-novel-JH11865-1-42 | 55 | 0 | 23 | Up | 6.5 | 1727 |
| ssc-miR-17-5p | 2868 | 438 | 23 | Up | 6.42 | 1443 |
| ssc-miR-16 | 11,873 | 1891 | 22 | Up | 6.25 | 1763 |
| ssc-miR-22-3p | 2267 | 365 | 22 | Up | 6.07 | 1487 |
| ssc-miR-146b | 75 | 3 | 21 | Up | 6.07 | 1139 |
| ssc-miR-155-5p | 426 | 62 | 22 | Up | 6.06 | 1146 |
| ssc-miR-novel-chr2-20965 | 52 | 1 | 23 | Up | 5.64 | 1147 |
| ssc-miR-novel-chrx-40705 | 758 | 147 | 22 | Up | 4.89 | 811 |
| ssc-miR-221-3p | 758 | 147 | 22 | Up | 4.89 | 811 |
| ssc-miR-301 | 114 | 17 | 23 | Up | 4.59 | 1509 |
| ssc-miR-191 | 741 | 156 | 23 | Up | 4.52 | 695 |
| ssc-miR-novel-chr6-31692 | 46 | 3 | 22 | Up | 4.30 | 2019 |
| ssc-miR-181a | 637 | 147 | 24 | Up | 4.12 | 1221 |
| ssc-miR-18a | 88 | 9541 | 22 | Down | 0.0102 | 995 |
| ssc-miR-novel-chr9-37990 | 20 | 1752 | 23 | Down | 0.0170 | 1512 |
| ssc-miR-novel-chr9-39041 | 20 | 1752 | 23 | Down | 0.0170 | 1512 |
| ssc-miR-novel-chr6-30729 | 13 | 1317 | 22 | Down | 0.0173 | 1083 |
| ssc-miR-424-5p | 33 | 2182 | 22 | Down | 0.0196 | 1817 |
| ssc-miR-31 | 55 | 3118 | 22 | Down | 0.0208 | 1149 |
| ssc-miR-novel-chrX-41190 | 0 | 431 | 21 | Down | 0.0227 | 335 |
| ssc-miR-novel-chr11-6750 | 7 | 547 | 18 | Down | 0.0305 | 1406 |
| ssc-miR-152 | 332 | 9880 | 21 | Down | 0.0346 | 1161 |
| ssc-miR-542-5p | 0 | 277 | 21 | Down | 0.0348 | 732 |
| ssc-miR-499-5p | 7 | 472 | 21 | Down | 0.0353 | 974 |
| ssc-miR-142-3p | 0 | 238 | 22 | Down | 0.0403 | 887 |
| ssc-miR-135 | 0 | 235 | 23 | Down | 0.0408 | 1602 |
| ssc-miR-194a | 13 | 541 | 21 | Down | 0.0417 | 842 |
| ssc-miR-361-5p | 20 | 704 | 22 | Down | 0.0420 | 867 |
| ssc-miR-185 | 59 | 1621 | 22 | Down | 0.0423 | 2285 |
| ssc-miR-193a-5p | 0 | 201 | 22 | Down | 0.0474 | 1142 |
| ssc-miR-novel-chr5-29676 | 0 | 199 | 23 | Down | 0.0478 | 1066 |
| ssc-miR-183 | 156 | 3132 | 23 | Down | 0.0528 | 1087 |
| ssc-miR-29c | 16 | 366 | 22 | Down | 0.0691 | 1120 |
| ssc-miR-novel-chr5-29857 | 42 | 736 | 19 | Down | 0.0697 | 1711 |
| ssc-miR-29a | 267 | 3939 | 23 | Down | 0.0701 | 1079 |
| ssc-miR-19a | 498 | 6339 | 23 | Down | 0.0800 | 1436 |
| ssc-miR-19b | 1161 | 14,587 | 23 | Down | 0.0802 | 1299 |
| ssc-miR--novel-chr13_10861 | 169 | 1483 | 22 | Down | 0.1199 | 857 |
| ssc-miR-21 | 52,611 | 382,830 | 22 | Down | 0.1374 | 789 |
Fig. 2RT-qPCR validation and expression analysis of differentially expressed miRNAs. The relative expression levels are presented as the mean and standard deviation (SD). **P < 0.01, *P < 0.05
GO analysis of swine target genes. The table shows the GO annotation of the upregulated gene (A) and downregulated gene (B) in biological process, cellular component and molecular function. Ten GO terms for each process are listed
| GO.ID | Term | Count |
|
|---|---|---|---|
| Biological process | |||
| GO:0009987 | cellular process | 1782 | 1.0102E-05 |
| GO:0008152 | metabolic process | 1350 | 2.44953E-27 |
| GO:0065007 | biological regulation | 1260 | 0.000424577 |
| GO:0044238 | primary metabolic process | 1231 | 5.99319E-26 |
| GO:0044237 | cellular metabolic process | 1221 | 1.70495E-28 |
| GO:0050789 | regulation of biological process | 1192 | 0.002408788 |
| GO:0050794 | regulation of cellular process | 1147 | 0.000216533 |
| GO:0002376 | immune system process | 273 | 1.35305E-08 |
| GO:0006955 | immune response | 163 | 1.37682E-05 |
| GO:0000165 | MAPK cascade | 79 | 3.28195E-05 |
| Cellular Component | |||
| GO:0044464 | cell part | 1772 | 1.04304E-42 |
| GO:0005623 | cell | 1772 | 1.25735E-42 |
| GO:0005622 | intracellular | 1589 | 1.48695E-38 |
| GO:0044424 | intracellular part | 1512 | 9.75601E-38 |
| GO:0043226 | organelle | 1258 | 3.15768E-22 |
| GO:0043229 | intracellular organelle | 1255 | 5.59497E-22 |
| GO:0005737 | cytoplasm | 1146 | 1.88382E-25 |
| GO:0043227 | membrane-bounded organelle | 1131 | 3.1329E-23 |
| GO:0043231 | intracellular membrane-bounded organelle | 1129 | 3.31685E-23 |
| GO:0044444 | cytoplasmic part | 886 | 1.59538E-15 |
| Molecular Function | |||
| GO:0005488 | binding | 1781 | 7.2806E-35 |
| GO:0005515 | protein binding | 1406 | 1.01651E-30 |
| GO:0003824 | catalytic activity | 791 | 4.12422E-11 |
| GO:0043167 | ion binding | 425 | 2.86598E-07 |
| GO:0043169 | cation binding | 423 | 3.71961E-07 |
| GO:0046872 | metal ion binding | 416 | 4.07808E-07 |
| GO:0003676 | nucleic acid binding | 368 | 0.010086661 |
| GO:0036094 | small molecule binding | 366 | 1.33205E-09 |
| GO:0000166 | nucleotide binding | 341 | 4.24208E-09 |
| GO:0097159 | organic cyclic compound binding | 341 | 4.47117E-09 |
| B | |||
| Biological Process | |||
| GO:0009987 | cellular process | 1732 | 0.000468457 |
| GO:0008152 | metabolic process | 1280 | 0.000101041 |
| GO:0065007 | biological regulation | 1226 | 0.039474247 |
| GO:0044238 | primary metabolic process | 1179 | 0.011728824 |
| GO:0044237 | cellular metabolic process | 1153 | 0.011728824 |
| GO:0050789 | regulation of biological process | 1150 | 0.022891558 |
| GO:0050794 | regulation of cellular process | 1100 | 0.023393923 |
| GO:0002376 | immune system process | 265 | 3.49438E-08 |
| GO:0006955 | immune response | 161 | 7.5883E-06 |
| GO:0022402 | cell cycle process | 151 | 0.001985807 |
| Cellular Component | |||
| GO:0044464 | cell part | 1699 | 1.61069E-32 |
| GO:0005623 | cell | 1699 | 1.89406E-32 |
| GO:0005622 | intracellular | 1506 | 1.8551E-26 |
| GO:0044424 | intracellular part | 1426 | 4.89384E-25 |
| GO:0043226 | organelle | 1212 | 8.24637E-20 |
| GO:0043229 | intracellular organelle | 1208 | 2.30659E-19 |
| GO:0043227 | membrane-bounded organelle | 1089 | 8.12018E-21 |
| GO:0043231 | intracellular membrane-bounded organelle | 1088 | 5.50768E-21 |
| GO:0005737 | cytoplasm | 1079 | 5.97213E-18 |
| GO:0044444 | cytoplasmic part | 836 | 2.48602E-11 |
| Molecular Function | |||
| GO:0005488 | binding | 1748 | 3.63499E-36 |
| GO:0005515 | protein binding | 1408 | 1.06202E-38 |
| GO:0003824 | catalytic activity | 743 | 5.00132E-07 |
| GO:0043167 | ion binding | 410 | 2.18765E-06 |
| GO:0043169 | cation binding | 408 | 2.81762E-06 |
| GO:0046872 | metal ion binding | 400 | 4.31756E-06 |
| GO:0003676 | nucleic acid binding | 365 | 0.004482893 |
| GO:0036094 | small molecule binding | 335 | 6.20944E-06 |
| GO:0000166 | nucleotide binding | 309 | 2.81002E-05 |
| GO:0097159 | organic cyclic compound binding | 309 | 2.91504E-05 |
Target genes of 17 differentially expressed miRNAs involved in immune response pathways
| KEGG pathways | Target genes | Differentially expressed microRNAs | FDR |
|---|---|---|---|
| T cell receptor signaling pathway | CTLA4, FYN, IKBKG, NFATC2, NCK1, CD8A, PIK3CG, CDC42, PTPN6, CD4, CD40LG, ICOS, PIK3R5, MAPK14, TNF, MAP3K7 | miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-19a, miR-122, miR-146b, miR-55-5p, miR-181a, miR-196b, let-7 g, let-7c | 8.89308E-12 |
| Toll-like receptor signaling pathway | CTSK, TLR7, MAP3K7, MAPK14, CXCL9, PIK3CG, NFKB1, CD40, STAT1, IL12B, CD86, IL6 | miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-21, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, miR-196b, let-7 g, let-7c | 1.04578E-07 |
| NF-kappaB signaling pathway | MAP3K7, CXCL12, DDX58, LCK, XIAP, ATM, VCAM1, NFKB1, TNF, CD40LG | miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, miR-196b | 1.18108E-06 |
| RIG-I-like receptor signaling pathway | MAP3K7, MAPK14, DHX58, DDX58, IKBKG, TANK, IKBKB, DDX3X, NFKB1, TNF, IL12B | miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-21, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, let-7c | 1.70355E-05 |
| Jak-STAT signaling pathway | JAK2, STAT4, STAT5B, JAK3, PIK3CG, PIM1, PTPN6, TYK2, MAPK14, STAT4, STAT1, IL7R, IL12B, IL6, PIK3R5, MYC | miR-9, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-21, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, miR-196b, let-7 g, let-7c | 0.000124339 |
| NOD-like receptor signaling pathway | MAP3K7, MAPK14, IKBKG, IKBKB, NFKB1, TNF, IL6 | miR-10b, miR-9, miR-17-5p, miR-16, miR-18a, miR-19b, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, let-7 g, let-7c | 0.001546381 |